NNNN
Anbio Biotechnology
$3.84
+$0.13 (+3.5%)Oct 28, 2026
Key metrics
The numbers that frame NNNN today
- Market cap
- $552.54M
- P/E (TTM)
- 26.1
- Gross margin
- 87.2%
- EV / Sales
- 63.0
- ROIC
- 46%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $3.09
- 52wk High
- $44.73
Growth
Revenue and earnings trend for NNNN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NNNN
Is Anbio Biotechnology a good buy?
No. Anbio Biotechnology has weak quality and poor momentum. Both signals point to a weaker setup. We think Anbio Biotechnology is selling at a high price.
What is the market capitalization of NNNN?
Anbio Biotechnology's market capitalization is $552.54M.
What is the P/E (TTM) ratio for NNNN stock?
Anbio Biotechnology's P/E (TTM) ratio is 26.1, based on trailing earnings.
What is the 52-week high for NNNN stock?
The 52-week high for Anbio Biotechnology is $44.73. The current close of $3.84 is 91.4% below that high.
What is the 52-week low for NNNN stock?
The 52-week low for Anbio Biotechnology is $3.09. The current close of $3.84 is 24.3% above that low.
Does NNNN stock pay dividends?
Anbio Biotechnology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NNNN?
Anbio Biotechnology's Debt / Equity ratio is 0.